Insight Molecular Diagnostics Inc. · NASDAQ:IMDX
Insight Molecular Diagnostics Inc. shareholders
As of Jun 30, 2026, 38 institutions reported holding Insight Molecular Diagnostics Inc., 56.4% of its shares. Largest: Broadwood Capital Inc, AWM Investment Company, Inc. and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Insight Molecular Diagnostics Inc. | Change | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 12.7M | 38.8% | +753K | Aug 14, 2026 |
| AWM Investment Company, Inc. | 2.84M | 8.7% | +30,436 | Aug 14, 2026 |
| Vanguard | 866K | 2.6% | +191K | Aug 13, 2026 |
| Pura Vida Investments, LLC | 485K | 1.5% | −462K | Aug 13, 2026 |
| Family Office Research LLC | 369K | 1.1% | +242K | Jul 27, 2026 |
| Geode Capital | 257K | 0.79% | −5,150 | Aug 12, 2026 |
| FNY Investment Advisers, LLC | 183K | 0.56% | −64,860 | Jul 8, 2026 |
| Jane Street | 158K | 0.48% | new | Aug 14, 2026 |
| BlackRock | 151K | 0.46% | +15,176 | Aug 7, 2026 |
| State Street | 92,124 | 0.28% | +41,370 | Aug 7, 2026 |